Competition Commission of India finds no prima facie case under Sections 3(4) and 4 of the Competition Act, 2002; Information closed against claims of coercive dealer practices and vertical restraints.
In a significant order dated 3rd September 2026, the Competition Commission of India (CCI) has dismissed allegations of abuse of dominant position and vertical restraints leveled by Vibrant Enterprise against Vygon India Pvt. Ltd., a company engaged in marketing and selling single-use medical devices.
The informant, Vibrant Enterprise, a distributor of medical devices based in Gujarat, accused Vygon India of engaging in coercive control and imposing restrictive conditions through its Master Dealership Agreement (MDA). The informant alleged that Vygon's practices, such as unilateral termination rights, tender prohibitions, market allocation, mandatory stocking, and shifting liability for expired products onto dealers, distorted competition in the market for neonatal and paediatric vascular access devices and specialty critical-care catheters used in tertiary care hospitals across India.
After thorough examination, the CCI noted that the informant failed to provide credible evidence establishing Vygon India's dominant position in the relevant market. The Commission observed that the market, defined broadly as the supply of medical consumables to institutional buyers in India, features several large multinational and domestic competitors, including Medtronic, Becton Dickinson, Polymed, and others, with Vygon's market share being negligible based on an Ernst & Young report presented by the company.
The Commission also found that the restrictive conditions challenged by the informant were applied across Vygon's entire product portfolio, not limited to neonatal PICCs as initially contended. Considering supply-side substitutability and the presence of alternative suppliers, the CCI concluded that the vertical restrictions did not cause or were unlikely to cause an appreciable adverse effect on competition.
Importantly, the informant's ability to secure a dealership with another manufacturer, Polymed, after terminating its relationship with Vygon was noted as indicative of the absence of foreclosure in the market.
The CCI's order under Section 26(2) of the Competition Act, 2002, closed the information without initiating an investigation. Additionally, the Commission granted confidentiality to certain documents filed by Vygon India for a period of three years in accordance with Regulation 36 of the Competition Commission of India (General Regulations), 2024.
This decision reaffirms the stringent standards required to establish abuse of dominance and the need for concrete evidence of market power and anti-competitive effects before the Commission proceeds with investigations.
Bottom Line:
Competition Law - Allegations of abuse of dominant position and vertical restraints - No prima facie case established against the Opposite Party under Sections 3(4) and 4 of the Competition Act, 2002.
Statutory provision(s):
Sections 3(4), 4, 19(1)(a), 19(3), 26(2), 57 of the Competition Act, 2002; Regulation 36 of the Competition Commission of India (General Regulations), 2024.
Vibrant Enterprise v. Vygon India Pvt. Ltd., (CCI) : Law Finder Doc Id # 2973478
